Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1159 |
Leflunomide
SU101,RS-34821,HWA486,来氟米特 |
Others; Dehydrogenase; AhR | Immunology/Inflammation; Metabolism; Others |
Leflunomide (HWA486) 是嘧啶合成抑制剂,能够抑制二氢乳清酸脱氢酶,具有抗风湿的活性。 | |||
T11020 |
DHODH-IN-11
|
Dehydrogenase; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Metabolism |
DHODH-IN-11 是一种来氟米特衍生物和弱二氢乳清酸脱氢酶 (DHODH) 抑制剂,pKa 为 5.03 | |||
T12438 |
PfDHODH-IN-1
|
Dehydrogenase; Parasite | Metabolism; Microbiology/Virology |
PfDHODH-IN-1 是 Leflunomide 活性代谢物的类似物,具有抗疟疾活性。它是恶性疟原虫二氢乳清酸脱氢酶抑制剂。 | |||
T11021 |
DHODH-IN-12
|
Dehydrogenase | Metabolism |
DHODH-IN-12 是一种 Leflunomide 衍生物,也是一种二氢乳清酸脱氢酶 (DHODH) 的弱抑制剂,其 pKa 为 5.07。 | |||
T7534 |
Teriflunomide
A 77-1726,特立氟胺 |
Others | Others |
Teriflunomide (A 77-1726) 是一种来氟米特的活性代谢产物,能够抑制嘧啶合成,有效降低T 细胞和B 细胞增殖,可用于研究类风湿性关节炎。 | |||
T35150 |
X 910279
MNA-279,X91 0279,HMR 279,HMR 1279,MNA 279 |
||
X 910279 is a leflunomide analog and a malononitrilamide. | |||
T11813 |
Laflunimus
HR325 |
Others | Others |
Laflunimus suppresses immunoglobulin (Ig) secretion, with IC50 values of 2.5 and 2 μM for IgM and IgG, respectively. Laflunimus also is a prostaglandin endoperoxide H synthase (PGHS) -1 and -2 inhibitor. Laflunimus is an immunosuppressive agent and an analogue of the Leflunomide-active metabolite A77 1726. Laflunimus is an orally active inhibitor of dihydroorotate dehydrogenase (DHODH). | |||
T11547 |
hDHODH-IN-2
|
Others | Others |
hDHODH-IN-2 is an analogue of the active metabolite of Leflunomide. hDHODH-IN-2 is a human dihydroorotate dehydrogenase (hDHODH) inhibitor with anti-inflammatory activity. |